This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ASM journals Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dupeyron, C Articles by Leluan, G Search for Related Content PubMed PubMed Citation Articles by Dupeyron, C Articles by Leluan, G

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1994 February; 38(2): 340-344

Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis.

C Dupeyron, N Mangeney, L Sedrati, B Campillo, P Fouet and G Leluan

Laboratoire de Bactériologie, Hôpital Albert Chenevier, Créteil, France.

ABSTRACT

We carried out quantitative culturing of stools from 31 hospitalized alcoholic patients with cirrhosis and ascites, before treatment with 400 mg of norfloxacin per day, weekly for the first month, and then every 2 weeks thereafter for 15 to 229 days (median, 54 days). Members of the family Enterobacteriaceae virtually disappeared from the stools (< 10(2)/g), but treatment had little effect on enterococci. No selection of resistant organisms occurred in 15 patients, but the remaining 16 patients developed fecal organisms resistant to fluoroquinolones between days 14 and 43 of treatment (median, 25 days). Staphylococcus aureus was isolated four times, coagulase-negative Staphylococcus spp. were isolated six times, Citrobacter freundii was isolated four times, Enterobacter cloacae was isolated three times, Klebsiella oxytoca was isolated twice, Proteus rettgeri was isolated once, and untypeable streptococci were isolated six times. Some isolates persisted, while others were transient (one to seven consecutively positive cultures). The MICs of four quinolones (nalidixic acid, norfloxacin, ofloxacin, and ciprofloxacin) were determined by use of experimental microwell strips (ATB CMI; Biomerieux S.A.). All the strains isolated before treatment were susceptible to the four quinolones, with low MICs, whereas those isolated during norfloxacin treatment were highly resistant. Long-term norfloxacin administration thus carries a risk of disturbing the bacterial ecology in these patients, suggesting that digestive decontamination should no longer be prescribed routinely to cirrhotic patients with ascites.

---

Antimicrob Agents Chemother. 1994 February; 38(2): 340-344

This article has been cited by other articles:

• Horcajada, J. P., Vila, J., Moreno-Martinez, A., Ruiz, J., Martinez, J. A., Sanchez, M., Soriano, E., Mensa, J. (2002). Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis. J Antimicrob Chemother 49: 55-59 [Abstract] [Full Text]  
• Steward, C. D., Stocker, S. A., Swenson, J. M., O'Hara, C. M., Edwards, J. R., Gaynes, R. P., McGowan, J. E. Jr., Tenover, F. C. (1999). Comparison of Agar Dilution, Disk Diffusion, MicroScan, and Vitek Antimicrobial Susceptibility Testing Methods to Broth Microdilution for Detection of Fluoroquinolone-Resistant Isolates of the Family Enterobacteriaceae. J. Clin. Microbiol. 37: 544-547 [Abstract] [Full Text]  
• Ditmanson, L. F., Apgar, D. A. (1996). Uncomplicate the Treatment of Uncomplicated Urinary Tract Infections. Arch Intern Med 156: 111-112 [Abstract]